CBL & Associates Properties Inc
Change company Symbol lookup
Select an option...
CBL-E CBL & Associates Properties Inc
HY Hyster-Yale Materials Handling Inc
CM Canadian Imperial Bank of Commerce
SFRFF Silver Fields Resources Inc
BAC Bank of America Corp
CHKJQ Chesapeake Energy Corp
ESPR Esperion Therapeutics Inc
AMZN Amazon.com Inc
VEEV Veeva Systems Inc
AVGO Broadcom Inc

Real Estate : Equity Real Estate Investment Trusts (REITs) | Small Cap Value
Company profile

CBL & Associates Properties, Inc. is a self-managed, self-administered, integrated real estate investment trust. The Company owns, develops, acquires, leases, manages and operates regional shopping malls, open-air and mixed-use centers, outlet centers, associated centers, community centers and office properties. The Company’s portfolio is comprised of approximately 108 properties totaling over 68.2 million square feet across 26 states and are primarily in the southeastern and midwestern United States. Its properties include over 68 enclosed, outlet and open-air retail centers and over nine properties managed for third parties.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
Day's Change
0.073 (10.28%)
B/A Size
Day's High
Day's Low

10-day average volume:

CVS shares jump premarket after earnings trounce estimates, company raises full-year guidance

6:51 am ET August 5, 2020 (MarketWatch)

CVS Health Corp. shares (CVS) soared 3.8% in premarket trade Wednesday, after the drugstore chain trounced estimates for the second quarter and raised its full-year guidance despite the impact of the coronavirus pandemic on its operations. The company had net income of $2.986 billion, or $2.26 a share, in the quarter, up from $1.931 billion, or $1.49 a share, in the year-earlier period. Adjusted per-share earnings came to $2.64, well ahead of the $1.91 FactSet consensus. Revenue rose to $65,341 billion from $63.431 billion, also ahead of the $64.004 billion FactSet consensus. The company said the COVID-19 pandemic adversely affected revenue in the retail and pharmacy services segments, mostly due to fewer new therapy prescriptions due to lower provider visits. Front store revenue was hurt by shelter-in-place orders. CVS raised its full-year EPS guidance and now expects it to range from $5.59 to $5.72, up from a prior range of $5.47 to $5.60. It expects adjusted EPS to range from $7.14 to $7.27 versus a prior range of $7.04 to $7.17. Shares have fallen 13% in the year to date, while the S&P 500 has gained 2.3%.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

August 05, 2020 06:51 ET (10:51 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.